Drug Repurposing for Cancers With Limited Survival: Protocol for a Retrospective Cohort Study

BACKGROUND: Only 5% of the molecules tested in oncology phase 1 trials reach the market after an average of 7.5 years of waiting and at a cost of tens of millions of dollars. To reduce the cost and shorten the time of discovery of new treatments, “drug repurposing” (research with molecules already a...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodríguez-Molinero, Alejandro, Pérez-López, Carlos, Salazar González, Jose L, Garcia-Lerma, Esther, Álvarez-García, Juan A, Soria Morillo, Luis M, Salas Fernández, Tomás
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2023
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10686206/
https://www.ncbi.nlm.nih.gov/pubmed/37962929
http://dx.doi.org/10.2196/48925

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10686206/
https://www.ncbi.nlm.nih.gov/pubmed/37962929
http://dx.doi.org/10.2196/48925

Ejemplares similares